A Novel Recombinant Fusion Protein Exhibited Inhibitory Activities on Platelet Aggregation and Thrombin

Author(s): Zongli Hu, Zhiping Zhao, Yan Liang, Yong Li, Guoping Chen

Journal Name: Letters in Drug Design & Discovery

Volume 7 , Issue 3 , 2010

Become EABM
Become Reviewer


We designed a novel recombinant fusion protein r-NAP5-hirudin 12-residue-RGD with bi-functional inhibitory activities against platelet aggregation and thrombin. Our strategy may supply a potential multi-functional drug for the prevention and management of thrombosis.

Keywords: Thrombosis, Hirudin 12-residue, Thrombin, NAP5, Platelet aggregation, Recombinant fusion protein

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [182 - 187]
Pages: 6
DOI: 10.2174/157018010790596605
Price: $65

Article Metrics

PDF: 3